Results 241 to 250 of about 358,018 (300)
Tumor‐Infiltrating mregDCs Restrain Anti‐Tumor Immunity in Early Relapse HCC
Tumor‐infiltrating mregDCs are regulated by the TNFR2‐non‐canonical NF‐κB axis, which is mediated by TNF‐α secreted by CD161+CD8+ T cells. These mregDCs recruit CD161+CD8+ T cells via the CCL20‐CCR6 axis, forming a positive feedback loop that enhances immunosuppression, promotes early recurrence of HCC, and further confirms TNFR2 as a key therapeutic ...
Zefan Zhang +13 more
wiley +1 more source
OXIDATION-REDUCTION POTENTIALS OF HORSERADISH PEROXIDASE
openaire +2 more sources
Ciclopirox Olamine Inhibits the NLRP3 Inflammasome to Alleviate Inflammatory Diseases
There is no drug targeting the NLRP3 inflammasome that has been approved for use in clinical settings. Ciclopirox olamine (CPX), an antifungal agent approved by the US Food and Drug Administration (FDA), is identified as a specific and potent NLRP3 inflammasome inhibitor. CPX targets the NACHT domain of NLRP3 at Y381 to impair NLRP3 oligomerization and
Xinyu Xia +7 more
wiley +1 more source
Supramolecular Assembly of Stepped‐Persistent ROS Nanogenerator for Sustained Tumor Immunotherapy
ROS catalytic systems often fail to achieve both effective tumor elimination and persistent immune activation due to their monotonous ROS production profiles. A stepped‐persistent ROS nanogenerator was developed by supramolecularly assembling multiple ROS generation modules within a nanofiber structure to simultaneously extend ROS generation duration ...
Zhenqiang Wang +10 more
wiley +1 more source
ABHD17C‐mediated depalmitoylation of BCL6B at Cys442 blocks its nuclear import and triggers ubiquitin‐dependent degradation, attenuating transcriptional repression of the anti‐phagocytic signal CD24. This mechanism enables pancreatic cancer cells to evade macrophage phagocytosis and fosters an immunosuppressive microenvironment.
Yalu Zhang +9 more
wiley +1 more source
A novel ultrasensitive chemiluminescence enzyme immunoassay by employment of a signal enhancement of horseradish peroxidase-luminol-hydrogen peroxide reaction for the quantitation of atezolizumab, a monoclonal antibody used for cancer immunotherapy. [PDF]
Darwish IA +3 more
europepmc +1 more source
The rapid anterograde transport of horseradish peroxidase
Intravitreal injections of horseradish peroxidase in the rat consistently resulted in the labelling of contralateral and ipsilateral efferents of the retina. Simultaneous intravitreal injections of horseradish peroxidase and tritiated amino acids yielded
M -M Mesulam +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The glycans of horseradish peroxidase
Carbohydrate Research, 1996Horseradish peroxidase (E.C. 1.11.1.7) isozyme c (HRPc) is a glycoprotein found to contain 21.8% carbohydrate with the average composition: 2 mol GlcNAc, 2.6 mol Man, and 0.8 mol each of Fuc and Xyl. The oligosaccharides of HRPc were investigated by a combination of High pH Anion-Exchange Chromatography with Pulsed Amperometric Detection, methylation ...
B Y, Yang, J S, Gray, R, Montgomery
openaire +2 more sources
Stereospecificity of horseradish peroxidase
Biological Chemistry, 2004We report here on the stereospecificity observed in the action of horseradish peroxidase (HRPC) on monophenol and diphenol substrates. Several enantiomers of monophenols and o-diphenols were assayed: L-tyrosinol, D-tyrosinol, L-tyrosine, DL-tyrosine, D-tyrosine, L-dopa, DL-dopa, D-dopa, L-alpha-methyldopa, DL-alpha-methyldopa, DL-adrenaline, D ...
M Angeles, Gilabert +6 more
openaire +2 more sources
Molecular and Cellular Biochemistry, 1981
Horseradish peroxidase C (HRP; ferric) reacts with H2O2 to form Compound I, with an equilibrium constant of about 10(14) M-1. Two-step reduction of Compound I to Compound II and further to the ferric enzyme occurs reversibly at Eo' values of 0.90 and 0.93 V (pH 7.0), respectively.
I, Yamazaki, M, Tamura, R, Nakajima
openaire +2 more sources
Horseradish peroxidase C (HRP; ferric) reacts with H2O2 to form Compound I, with an equilibrium constant of about 10(14) M-1. Two-step reduction of Compound I to Compound II and further to the ferric enzyme occurs reversibly at Eo' values of 0.90 and 0.93 V (pH 7.0), respectively.
I, Yamazaki, M, Tamura, R, Nakajima
openaire +2 more sources

